Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 67,000 shares at $86.46 ($5.8M) on 2024-02-13, disclosed to the SEC on 2024-02-15.
Seasonal sale ($5.8M) by CVP, Critical Care — this insider has traded EW in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $86.46 | 20,000 | $1.7M | 30.0% |
| 2 | $86.46 | 20,000 | $1.7M | 30.0% |
| 3 | $85.62 | 27,000 | $2.3M | 40.1% |
| Total | $86.12 avg | 67,000 | $5.8M | 100% |
| Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |
| EW | SELL | 2023-06-13 | $429K | — | Filing → |